QGLY The Quigley (MM)

The Quigley Corporation (NASDAQ: QGLY), manufacturer and distributor of the clinically proven cold remedy, Cold-EEZE®, announced today the release of a new online video series aimed at educating the public about staying healthy during the cold season. The series, reported and hosted by physician and medical correspondent Dr. Bob Arnot, offers critical information about treating, beating and even preventing the common cold. The videos will be available to millions of viewers on a variety of targeted Internet outlets.

Each year millions of people contract the common cold. This cold season has been particularly difficult because of the H1N1 and seasonal flu outbreaks. The common cold weakens the immune system leaving the sufferer at risk for developing advanced infections. The videos offer information to the public that can increase the chances of remaining healthy.

"The fact that we make a product that has been clinically proven to reduce the duration and severity of the common cold, certainly helped drive our decision to underwrite the series," noted Ted Karkus, CEO of The Quigley Corporation. "We believe the information has great value to anyone at risk for the common cold, which of course, is everyone."

"More than 80% of what the public knows about medicine they know from television news style stories," said Dr. Arnot. "These are clear and easy to comprehend. We're delighted to follow Ted Karkus' far sighted leadership role in bringing these to an Internet audience which far exceeds the numbers possible on TV and with valuable expert knowledge that can improve the health of tens of millions of viewers."

The videos explore ways to engage in early treatment of the common cold as well as research relating to prevention and symptom reduction. Dr. Bob Arnot hosts and reports from Vermont, Utah and New Hampshire with reviews of some of the latest scientific literature and interviews with healthcare professionals.

For more information about Cold-EEZE, please visit our website at www.coldeeze.com.

About The Quigley Corporation

The Quigley Corporation (NASDAQ: QGLY) (http://www.Quigleyco.com) is a diversified natural health medical science company. Its Cold Remedy segment is a leading marketer and manufacturer of the Cold-EEZE® family of lozenges and sugar free tablets clinically proven to significantly reduce the severity and duration of the common cold. Cold-EEZE® customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. The Quigley Corporation has several wholly owned subsidiaries including Quigley Manufacturing Inc., which consists of an FDA approved facility to manufacture Cold-EEZE® lozenges and fulfill other contract manufacturing opportunities, and Quigley Pharma, Inc. (http://www.QuigleyPharma.com), which conducts research in order to develop and commercialize a pipeline of patented botanical and naturally derived potential prescription drugs.

Forward-Looking Statements

Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve known and unknown risk, uncertainties and other factors that may cause the Company's actual performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statement. Factors that impact such forward-looking statements include, among others, changes in worldwide general economic conditions, changes in interest rates, government regulations, and worldwide competition.

Media Relations: The Lexicomm Group Wendi Tush Email Contact (212) 794-4531 Lindsey Gardner Email Contact (570) 479-4895 Investor Contact: Ted Karkus Chairman and CEO The Quigley Corporation 215.345.0919 x 0